Dergiler / Journal of Experimental and Clinical Medicine / 2026 / Volume: 35 Issue: 1

Two multiple sclerosis cases developed herpes zoster during use of fingolimod

Sayfa
—
Yayın Tarihi
2019-10-25
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this article, the information of two cases with varicella-zoster virus reactivation during fingolimod use were presented.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system.
📊
Temel Bulgular & Veri:Immunosuppressive and immunomodulating drugs are used during disease monitoring.
💡
Sonuç & Katkı:In this article, the information of two cases with varicella-zoster virus reactivation during fingolimod use were presented.
🔬Tür:Case Report
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Fingolimod · Multiple sclerosis · Varicella-zoster virus reactivation

Abstract

Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Immunosuppressive and immunomodulating drugs are used during disease monitoring. Fingolimod is one of the immunomodulatory treat - ments used in MS patients. It is a therapeutic agent acting on lymphocytes. La - tent varicella-zoster virus infections may occur in MS patients receiving fingo - limod therapy. In this article, the information of two cases with varicella-zoster virus reactivation during fingolimod use were presented.

🔖

Bu Makaleye Atıf Yap

Terzi, M., Duman, T., Şen, S., Güntel, M., Şen, N. O. (2019). Two multiple sclerosis cases developed herpes zoster during use of fingolimod. Journal of Experimental and Clinical Medicine, Volume: 35 Issue: 1. https://ajindex.com/articles/1423389

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Ahmed, A.M., Brantley, J.S., Madkan, V., Mendoza, N., Tyring, S.K., 2007. Managing herpes zoster in immunocompromised patients. Herpes. 14, 32-6.
  2. Bennett, G.J., 1994. Hypotheses on the pathogenesis of herpes zoster associated pain. Ann Neurol. 35, 38-41.
  3. Brody, M.B., Moyer, D., 1997. Varicella-zoster virus infection. Postgrad Med. 102(1), 187–94.
  4. Cohen, J.I., Brunell, P.A., Straus, S.E., Krause, P.R., 1999. Recent advances in varicella-zoster virus infection. Ann Intern Med.130, 922-32.
  5. Cohen, J.A., Barkhof, F., Comi, G., Hartung, H.P., Khatri, B.O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., Tiel-Wilck, K., de Vera, A., Jin, J., Stites, T., Wu, S., Aradhye, S., Kappos, L., Transforms Study Group., 2010. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 362, 402-15.
  6. Dworkin, R.H., Johnson, R.W., Breuer, J., Gnann, J.W., Levin, M.J., Backonja, M., Betts, R.F., Gershon, A.A., Haanpaa, M.L., McKendrick, M.W., Nurmikko, T.J., Oaklander, A.L., Oxman, M.N., Pavan-Langston, D., Petersen, K.L., Rowbotham, M.C., Schmader, K.E., Stacey, B.R., Tyring, S.K., van Wijck, A.J., Wallace, M.S., Wassilew, S.W., Whitley, R.J., 2007. Recommendations for the management of herpes zoster. Clin Infect Dis. 44(1), 1-26.
  7. Gnann, J.W. Jr., Whitley, R.J., 2002. Clinical practice: herpes zoster. N Engl J Med. 347, 340-6. Kappos, L., Radue, E.W., O’Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang- Auberson, L., Burtin, P., Freedoms Study Group., 2010. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 362, 387-401.
  8. Ricklin, M.E., Lorscheider, J., Waschbisch, A., Paroz, C., Mehta, S.K., Pierson, D.L., Kuhle, J., Fischer-Barnicol, B., Sprenger, T., Lindberg, R.L., Kappos, L., Derfuss, T., 2013. T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology. 9, 81(2), 174-81.
  9. Strauss, S.E., 1994. Overview: the biology of varicella-zoster virus infection. Ann Neurol. 35, 4–8.
  10. Uccelli, A., Ginocchio, F., Mancardi, G.L., Bassetti, M., 2011. Primary varicella zoster infection associated with fingolimod treatment.Neurology. 15, 76(11), 1023-4.
  11. Weinberg, J.M., 2007. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 57, 130-5. Winkelmann, A., Löbermann, M., Reisinger, E.C., Zettl, U.K. 2012. Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations. Nervenarzt. 83(2), 236-42.